Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • December 2006 | Volume 19 - Issue 12
    By Jeff Hall, Executive Editor
    1,753 reads | 0 comments | 12/03/06
        How bad have things gotten at the Food and Drug Administration (FDA)? When you consider some of the recent reports and developments over the past few months, it is clear that the FDA has significant credibility issues.     In June, a report by U.S. Rep. Henry A. Waxman revealed some eye-opening trends in FDA enforcement actions in recent years. According to the report, which reportedly involved an investigation and review of copious internal agency enforcement documentation, there was a greater than 50 percent decrease from 2000 to 2005 in the number of FDA ... continue reading
    By Gary “Dock” Dockery, DPM, FACFAS
    76,439 reads | 0 comments | 12/03/06
          A 29-year-old Caucasian female patient presented in consultation in the foot and ankle clinic regarding a six-week history of erythematous vesicles and papules on the soles. She reported intense pruritus. Her primary care physician told her that she had a case of “athlete’s feet” and that she should use an over-the-counter (OTC) antifungal cream. After two weeks of treatment with antifungal cream, the patient had no improvement. ... continue reading